Decisive Action Needed to Increase Patient Access to Hepatitis C Treatment

"Pharmaceutical pricing for HCV is unconscionable," Dr. Edlin said. "They are extortionist prices because the choice is really your money or your life. And the restrictions payers have imposed defy medical guidelines, lack scientific justification, and undermine public health efforts to stem transmission and end the epidemic." Despite the approval of effective hepatitis C virus (HCV) treatment regimens, the exceedingly high cost of the medication prevents...